At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage.
“The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Posted in Events | Also tagged American Museum of Natural History, business, Clinical trial, Elie Wiesel, GlaxoSmithKline, Harvard School of Public Health, Health, Health care, Jeffrey Sachs, Pharmaceutical drug, Prix Galien, Public health, United States
PharmExec Blog
Follow Us
RSS
Bookstore
Pharma Celebrates its Own